000			01406 a2200397 4500
005			20250511224313.0
264		0	_c19910514
008			199105s 0 0 eng d
022			_a0167-6997
024	7		_a10.1007/BF00198592 _2doi
040			_aNLM _beng _cNLM
100	1		_aConley, B A
245	0	0	_aTolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function. _h[electronic resource]
260			_bInvestigational new drugs _cNov 1990
300			_a365-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrugs, Investigational _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKidney Diseases _xmetabolism
650	0	4	_aLiver Diseases _xmetabolism
650	0	4	_aMale
650	0	4	_aMenogaril
650	0	4	_aMiddle Aged
650	0	4	_aNogalamycin _xadministration & dosage
650	0	4	_aProspective Studies
700	1		_aEgorin, M J
700	1		_aSinibaldi, V
700	1		_aVan Echo, D A
773	0		_tInvestigational new drugs _gvol. 8 _gno. 4 _gp. 365-7
856	4	0	_uhttps://doi.org/10.1007/BF00198592 _zAvailable from publisher's website
999			_c2156818 _d2156818